Drug repurposing using biological networks

22Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

Abstract

Drug repositioning is a strategy to identify new uses for existing, approved, or research drugs that are outside the scope of its original medical indication. Drug repurposing is based on the fact that one drug can act on multiple targets or that two diseases can have molecular similarities, among others. Currently, thanks to the rapid advancement of high-performance technologies, a massive amount of biological and biomedical data is being generated. This allows the use of computational methods and models based on biological networks to develop new possibilities for drug repurposing. Therefore, here, we provide an in-depth review of the main applications of drug repositioning that have been carried out using biological network models. The goal of this review is to show the usefulness of these computational methods to predict associations and to find candidate drugs for repositioning in new indications of certain diseases.

Cite

CITATION STYLE

APA

Somolinos, F. J., León, C., & Guerrero-Aspizua, S. (2021, June 1). Drug repurposing using biological networks. Processes. MDPI AG. https://doi.org/10.3390/pr9061057

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free